Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Zn2+ decoration of microtubules arrests axonal transport and displaces tau, doublecortin, and MAP2C. | J Cell Biol | 2023 | 37326602 | PubTator, text mining | PubMed |
| Molecular characterization of MET fusions from a large real-world Chinese population: A multicenter study. | Cancer Med | 2023 | 37326363 | PubTator, text mining | PubMed |
| Ectopic ATP synthase stimulates the secretion of extracellular vesicles in cancer cells. | Commun Biol | 2023 | 37322056 | PubTator, text mining | PubMed |
| Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial. | JCO Precis Oncol | 2023 | 37315261 | PubTator, text mining | PubMed |
| Overview of Molecular Detection Technologies for MET in Lung Cancer. | Cancers (Basel) | 2023 | 37296895 | PubTator, text mining | PubMed |
| RNA recoding in cephalopods tailors microtubule motor protein function. | Cell | 2023 | 37295401 | PubTator, text mining | PubMed |
| Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer. | Front Oncol | 2023 | 37274265 | PubTator, text mining | PubMed |
| FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors. | Clin Cancer Res | 2023 | 37265412 | PubTator, text mining | PubMed |
| Selpercatinib monotherapy in a Chinese patient with RET fusion/ EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report. | Anticancer Drugs | 2023 | 37265026 | PubTator, text mining | PubMed |
| KIF1A-Associated Neurological Disorder: An Overview of a Rare Mutational Disease. | Pharmaceuticals (Basel) | 2023 | 37259299 | PubTator, text mining | PubMed |
| Insulin signalling and GLUT4 trafficking in insulin resistance. | Biochem Soc Trans | 2023 | 37248992 | PubTator, text mining | PubMed |
| Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques. | Mol Oncol | 2023 | 37243883 | PubTator, text mining | PubMed |
| You Shall Not Pass: MX2 Proteins Are Versatile Viral Inhibitors. | Vaccines (Basel) | 2023 | 37243034 | PubTator, text mining | PubMed |
| Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort. | Int J Mol Sci | 2023 | 37239898 | PubTator, text mining | PubMed |
| Organelle Membrane Extensions in Mammalian Cells. | Biology (Basel) | 2023 | 37237478 | PubTator, text mining | PubMed |
| Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running? | Curr Oncol | 2023 | 37232842 | PubTator, text mining | PubMed |
| Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families. | J Cell Sci | 2023 | 37232246 | PubTator, text mining | PubMed |
| Equal distribution of lipid droplets in daughter cells is regulated by microtubules. | Cell Cycle | 2023 | 37218663 | PubTator, text mining | PubMed |
| Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement. | Cancer Res Treat | 2023 | 37218138 | PubTator, text mining | PubMed |
| Microtubule detyrosination drives symmetry breaking to polarize cells for directed cell migration. | Proc Natl Acad Sci U S A | 2023 | 37216553 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=14